Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      The Cannabinoid Derived Pharmaceutical Market worth US$ 11.2 Billion by 2030 - Exclusive Report by InsightAce Analytic

      This image opens in the lightbox

      News provided by

      InsightAce Analytic Pvt. Ltd

      03 Feb, 2022, 11:00 GMT

      Share this article

      Share this article


      JERSEY CITY, N.J., Feb. 3, 2022 /PRNewswire/ -- The newly published report titled "Global Cannabinoid Derived Pharmaceutical Market – By Trends, Industry Competition Analysis, Pipeline Analysis, COVID-19 Analysis, Revenue (US$ Millions) and Forecast Till 2030." features detailed industry analysis and an extensive clinical trial/pipeline study on the market, exploring its significant factors.

      According to the latest pharmaceutical market research report by InsightAce Analytic, the global cannabinoid-derived pharmaceutical market size was valued at US$ 636.8 Million in 2021, and it is expected to reach US$ 11,243.2 Million in 2030, record a promising CAGR of 37.7% from 2022 to 2030.

      Get the Sample Report: https://www.insightaceanalytic.com/request-sample/1042

      Cannabinoids or medical marijuana are widely accessed medicinal compounds derived from the cannabis plant of the Cannabaceae family. The interest in the cannabis plant and its derived products has increased considerably in the last few years. Due to the pharmacological potential of cannabis, it has applications in the treatment of various diseases and conditions, including diabetes, cancer, epilepsy, chronic pain, depression, glaucoma, arthritis, neurological disorders, and others. It is safer and has less severe side effects than other treatment options, and it also can combat adverse side effects. Hence, cannabis is approved for medical use in many countries, with varying legal limitations.

      The growing therapeutic applications of cannabinoids in human medicine, surging use and acceptance of CBD in numerous countries, and the rising consumer preference for cannabis-derived products are projected to propel the cannabinoid-derived pharmaceutical industry over the forecast period. The market is further driven by the increasing CBD-related clinical research activities, ongoing clinical trials of cannabis-based drugs, growing awareness about the medical benefits of plant-derived cannabidiol products, and the commercialization of cannabis-based indications. However, the manufacturing inefficiencies and the legal restrictions on cannabinoid-derived products in various countries may impede the CBD products demand in the upcoming years.

      Preview for Detailed TOC: https://www.insightaceanalytic.com/report/global-cannabinoid-derived-pharmaceutical-market-assessment/1042

      The prominent players in the cannabinoid derived pharmaceutical industry include:

      Cara Therapeutics, Inc., Arena Pharmaceuticals, Cannabics Pharmaceuticals Inc., Echo Pharmaceuticals, GW Pharmaceuticals, InMed Pharmaceuticals, INSYS Therapeutics, Inc., LaraPharm, MGC Pharmaceuticals, Ltd., One World Cannabis, Orpheus Medica, Receptor Life Sciences, RespireRx Pharmaceuticals, Tetra Bio-Pharma, Cardiol Therapeutics, United cannabis Corporation, Zynerba Pharmaceuticals,  Alterola Biotech Inc., BOL Pharma, and Other Prominent Players.

      Upsurging clinical studies on the CBD to determine its effectiveness for various conditions create an opportunity for pharmaceutical companies to add another portfolio of treatments to their current pipelines.

      Key Industry Developments from Leading Players:

      • In Aug 2021, GW Pharmaceuticals (part of Jazz Pharmaceuticals plc) received the UK Medicines and Healthcare Products Regulatory Agency (MHRA) approval for EPIDYOLEX (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex (TSC) for patients two years of age and older.
      • In May 2021, Jazz Pharmaceuticals acquired GW Pharmaceuticals plc, a leader in the science, development, and commercialization of cannabinoid-based prescription medicines.
      • In Dec 2021, Pfizer entered the medical cannabis industry betting on a promising cannabinoid-based bowel disease treatment. Pfizer acquired the clinical-stage company Arena Pharmaceuticals for a total equity value of around $6.7 billion.

      Cannabinoid Derived Pharmaceutical Market Regional Analysis:

      North America is anticipated to lead the cannabinoid-derived pharmaceutical market over the projected period (2022 to 2030). The major drivers of market expansion are the updated legalization of cannabis in North America for medical use and the increased adoption of CBD-based products for treating various medical conditions in this region. Recent legislation of cannabis allowing the use of cannabinoids products in more than 23 U.S states has compelled manufacturers' interest in innovating pharmaceutical-derived cannabis products to treat several clinical conditions.

      Europe is predicted to hold the highest market share during the forecast years, followed by the Asia Pacific. The growing usage of the cannabis plant and its derived products and the increasing awareness about the benefits of CBD products boosts the market demand in this region. For instance, in October 2020, STADA, the largest pharmaceutical company in Europe, partnered with Medipharm. Under this partnership, Medipharm supplies GMP-certified medical cannabis for STADA, market-derived products in Germany and other European countries.

      Furthermore, factors such as the increasing government funding for clinical research and the legalization of cannabidiol-derived products are estimated to contribute to market growth in the Asia Pacific region.

      Inquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1042

      The Global Cannabinoid Derived Pharmaceutical Market Segments

      The Global Cannabinoid Derived Pharmaceutical Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Product

      • Epidiolex
      • Sativex
      • Other Pipeline Products

      The Global Cannabinoid Derived Pharmaceutical Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Molecule Type

      • Cannabinoid Receptor Type 1 (CB1)
      • Cannabinoid Receptor Type 2 (CB2)
      • Others

      The Global Cannabinoid Derived Pharmaceutical Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Disease Indication

      • Alzheimer's Disease
      • Autism
      • Cancer
      • Chronic Pain
      • Epilepsy
      • Migraine
      • Multiple Sclerosis
      • Schizophrenia
      • Others

      The Global Cannabinoid Derived Pharmaceutical Market Estimates (Value US$ Million) & Forecasts and Trend Analyses, 2019 to 2030 based on Region

      • Europe
      • North America
      • Latin America
      • Asia Pacific
      • Middle East & Africa

      North America Cannabinoid Derived Pharmaceutical Market Estimates Revenue (US$ Million) by Country, 2019 to 2030

      • U.S.
      • Canada

      Europe Cannabinoid Derived Pharmaceutical Market Estimates Revenue (US$ Million) by Country, 2019 to 2030

      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe

      Asia Pacific Cannabinoid Derived Pharmaceutical Market Estimates Revenue (US$ Million) by Country, 2019 to 2030

      • India
      • China
      • Japan
      • South Korea
      • Australia & New Zealand

      Latin America Cannabinoid Derived Pharmaceutical Market Estimates Revenue (US$ Million) by Country, 2019 to 2030

      • Brazil
      • Mexico
      • Rest of Latin America

      The Middle East & Africa Cannabinoid Derived Pharmaceutical Market Estimates Revenue (US$ Million) by Country, 2019 to 2030

      • South Africa
      • GCC Countries
      • Rest of the Middle East & Africa

      For Customised Information @ https://www.insightaceanalytic.com/customisation/1042

      Other Related Reports Published by InsightAce Analytic:

      Global COVID-19 Therapeutics Market

      Global Fragment-Based Drug Discovery Market

      Global mRNA Synthesis and Manufacturing Services Market

      About Us:

      InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

      Contact Us:

      Priyanka Tilekar
      InsightAce Analytic Pvt. Ltd.
      Visit: www.insightaceanalytic.com
      Tel : +1 551 226 6109
      Asia: +91 79 72967118
      Email: info@insightaceanalytic.com
      Follow Us on LinkedIn @ bit.ly/2tBXsgS
      Follow Us On Facebook @ bit.ly/2H9jnDZ

      Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg

      Modal title

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.